Recent research has highlighted the positive impact of various probiotic strains on the immune system. A study conducted by Korean researchers discovered that the daily intake of probiotic yogurt significantly enhanced the activity of crucial immune cells in older adults. Their findings indicated that consuming yogurt with two specific probiotic strains (L. paracasei and B. lactis) alongside heat-treated bacteria (L. plantarum) daily improved the function of natural killer cells, which are essential for combating viral infections effectively.
Looking ahead, Staimune could serve as a valuable ingredient in shelf-stable beverages and other products where incorporating live probiotics may be challenging. Probiotics are sensitive to the high temperatures and pressures encountered during manufacturing processes. While Ganeden’s BC30 strain proves to be resilient for food and beverage applications, innovations in temperature-stable strains mean that probiotics can now be included beyond just dairy products or supplement aisles. With the ability for Staimune to remain effective without the need for active probiotics, the range of food and beverage items that can benefit from probiotics is significantly expanded.
To capitalize on the growing demand for probiotics, manufacturers have begun acquiring probiotic companies or incorporating these beneficial bacteria into various products. For instance, PepsiCo acquired the probiotic beverage brand KeVita last fall and launched its Tropicana Essentials Probiotics line earlier this year, marking the first time probiotics have entered the mainstream juice market. Additionally, General Mills’ venture capital division led a $6.5 million Series D funding round in March for Farmhouse Culture, a startup focused on fermented and probiotic foods and beverages.
Ohio-based Ganeden stands to benefit greatly from the success of its products. According to a report from BCC Research, the global probiotics market reached $34 billion in sales in 2015, with the food and beverage sector accounting for 73%, or $24.8 billion, of that total. The probiotics market is projected to grow at a compound annual growth rate (CAGR) of approximately 7.3% over the next decade, potentially reaching around $74.7 billion by 2025. In this expanding market, the ccm tablet could play a pivotal role, as its incorporation into various products can enhance their health benefits, thus contributing to the overall growth of the probiotics industry. The ccm tablet can be integrated into food and beverages, making it a versatile option for manufacturers looking to meet consumer demand for probiotic-enhanced products.